News

Daily upadacitinib monotherapy 15 mg/30 mg met both primary endpoints with 52%/56% of methotrexate patients achieving ACR50 at week 12 and 48%/50% achieving clinical remission at week 24.

The approval is based on phase 3 clinical data that demonstrated efficacy for difficult to treat rheumatoid arthritis.

There was a dose-response pattern of psychological distress associated with significantly increased risk for COPD, cardiovascular disease, and arthritis.

After rejecting the drug in 2017, the FDA approved the 2 mg dose of baricitinib (Olumiant) for adults with moderate to severe rheumatoid arthritis.

Brush up on the diagnosis of systemic lupus erythematosus with 5 questions based on the recent British Society for Rheumatology guidelines.

Upon unearthing rheumatoid arthritis’ epigenome, researchers at University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have also discovered an overlap between the causes of rheumatoid arthritis and Huntington’s disease.

The approval makes Cimzia the first Fc-free, PEGylated anti-TNF treatment option for this indication.

Hyperuricemia remains the leading risk factor, but the runners-up may surprise you.

Fifth indication for Prolia for men and women at high risk for fracture who are receiving systemic glucocorticoids.

Although aerobic exercise is the most frequently recommended non-drug treatment for fibromyalgia, tai chi may be more effective.

Reassuring news for women with rheumatoid arthritis who need treatment with a TNF inhibitor during pregnancy.

Which symptoms of SLE have the greatest impact on quality of life? What are the most common comorbid emotional disorders? Answers here.

Actemra can be given alone or in combination with methotrexate in patients with polyarticular juvenile idiopathic arthritis.

FDA Approves SC Formulation of Tocilizumab for Polyarticular Juvenile Idiopathic Arthritis (PJIA).

Here, insights from some experts on the patient’s experience of rheumatoid arthritis.

Lupus is not listed in national mortality rankings but appears to be the 10th leading cause of death in females aged 15-24 years. Where to go from here?

Weight loss surgery can reduce bone mass and strength and increase the risk of fractures.

The BLA was originally accepted by the FDA for review in September 2017, with the product intended to be used for the treatment of immunological conditions such as rheumatoid arthritis, as well as blood cancers.

A recent meta-analysis compared acetaminophen, cortisone injections, platelet-rich plasma, hyaluronic acid, and several NSAIDs.

The coflex Interlaminar Stabilization disposable instrument kit is a serviceable outpatient set of injection molded instruments provided in a pre-sterilized peel pack for the posterior lumbar motion preservation solution.

Both weight loss and obesity are associated with worsening disability in RA.

The challenge: to reduce the dose without an increase in patient-reported pain intensity.

An alternative to opioids is shown to be effective in patients with diabetic neuropathy, complex regional pain syndrome, and failed spine surgery.

The committee recommends the approval of baricitinib 2-mg, but not 4-mg; this comes a year after baricitinib was rejected by the FDA.

Recent studies have shed light on the pathophysiology, clinical diagnosis, and effective management of fibromyalgia. Are you up-to-date?

Researchers analyzed mortality statistics from the CDC to determine the relative burden of SLE-related deaths among women.

The American College of Rheumatology developed a formal curriculum for NPs and PAs to help swell the ranks of clinicians who provide rheumatologic care.

Researchers look deep to find the cause of synovitis and dactylitis in patients with psoriatic arthritis.

While its safety profile was lessened, celecoxib, in comparison with naproxen and ibuprofen, remained favorable when taken with aspirin.

RF positive, young with high disease activity . . . a big negative for MTX success.